Healthcare
CVS Health Corp(CVS)
Live Price
Offline$98.32
-0.85% today
1Y Change
+48.14%
Window
Jun 25, 2025 โ Jun 18, 2026
- Market Cap
- $103.41B
- Revenue Growth
- +7.8%
- EPS Growth
- -61.7%
- Dividend Yield
- 3.3%
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
CVS Health Corp (CVS) is a Healthcare stock with a market cap of $103.41B and listed on NYSE. The stock last traded around $98.32 and up 48.1% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +7.8%, EPS growth of -61.7%, a dividend yield of 3.3%. What stands out right now is revenue +7.8%, EPS -61.7%, free cash flow +23.4% with operating margin 1.2% and ROIC 2.1%. The dividend matters to the case here, with a current yield around 3.3%. Valuation already assumes a fairly strong business story at P/E 58.0 and price/sales 0.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CVS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+7.8% vs +7.6% peer median
Operating Margin
Below sector median
+1.2% vs +19.4% peer median
P/E
Above sector median
58.0 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 7, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +7.8% and EPS is at -61.7%, with operating margin around 1.2%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 3.3%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +3.8% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 7, 2026 | โ | +3.7% | +11.2% | +9.8% |
2026 Feb 10, 2026 | +9.0% | +1.7% | +2.7% | +0.0% |
2025 Oct 29, 2025 | +16.8% | -4.9% | -2.5% | -0.9% |
Benchmark Edge
CVS vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CVS
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CVS Max Drawdown
-16.44%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CVS and SPY.
Company Overview
CVS Health Corp
NYSE
CVS Health Corporation is an American multinational healthcare company renowned for integrating retail pharmacy, pharmacy benefits management, and health insurance services. Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, by brothers Stanley and Sidney Goldstein and partner Ralph Hoagland, it has grown into the world's second-largest healthcare company, behind UnitedHealth Group, with headquarters in Woonsocket, Rhode Island. The company operates through key segments: CVS Pharmacy, the largest U.S. retail pharmacy chain with over 9,600 stores across all 50 states, filling one in five prescriptions; CVS Caremark, a leading pharmacy benefits manager serving employers, insurers, and plans with mail-order, specialty, and infusion services; Aetna, a major health insurer; CVS Specialty for complex chronic disease therapies; and additional units like MinuteClinics, Omnicare for long-term care, and Oak Street Health primary care centers. Employing around 300,000 people, CVS Health Corporation plays a pivotal role in the healthcare ecosystem by enhancing access to medications, wellness services, and integrated care solutions for millions nationwide.
- Leadership
- Mr. J. David Joyner CEBS
- Employees
- 219.0k
- Street Address
- One CVS Drive, 11 Bermudiana Road
- Mailing
- Woonsocket, RI, 02895
- Region
- Woonsocket, RI, United States
- Last Updated
- May 9, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 58.0
- EV/EBITDA
- 19.1
- Price/Sales
- 0.3
- Price/Book
- 1.4
Growth
- Revenue
- +7.8%
- EPS
- -61.7%
- Free Cash Flow
- +23.4%
Profitability
- Gross Margin
- 13.8%
- Operating Margin
- 1.2%
- Net Margin
- 0.4%
- ROE
- 2.3%
- ROIC
- 2.1%
Balance Sheet
- Debt/Equity
- 1.24
- Current Ratio
- 0.84
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.